Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia. | Expert Opin Pharmacother | 2025 | 39794291 | PubTator, text mining | PubMed |
| Identifying Biomarkers for Atherosclerosis via Gene Expression and Biological Networking. | Curr Cardiol Rev | 2025 | 39773060 | PubTator, text mining | PubMed |
| Cutting-edge lipid-lowering pharmacological therapies: Improving lipid control beyond statins. | Hipertens Riesgo Vasc | 2025 | 39765369 | PubTator, text mining | PubMed |
| ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer. | Transl Oncol | 2025 | 39708716 | PubTator, text mining | PubMed |
| Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL Study. | J Atheroscler Thromb | 2025 | 39694503 | PubTator, text mining | PubMed |
| An up-to-date review of emerging biologic therapies for hypercholesterolemia. | Expert Opin Biol Ther | 2025 | 39668448 | PubTator, text mining | PubMed |
| Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial. | JAMA Cardiol | 2025 | 39661372 | PubTator, text mining | PubMed |
| Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality. | Circulation | 2025 | 39392008 | PubTator, text mining | PubMed |
| Novel insights into causal effects of serum lipids, lipid metabolites, and lipid-modifying targets on the risk of intracerebral aneurysm. | Eur Stroke J | 2025 | 39081035 | PubTator, text mining | PubMed |
| ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque. | J Adv Res | 2025 | 38740260 | PubTator, text mining | PubMed |
| A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia. | Med Res Arch | 2024 | 40896709 | PubTator, text mining | PubMed |
| Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease. | Front Endocrinol (Lausanne) | 2024 | 39877840 | PubTator, text mining | PubMed |
| Construction and evaluation of a prognostic model for metabolism-related genes in kidney renal clear cell carcinoma using TCGA database. | Am J Clin Exp Urol | 2024 | 39839750 | PubTator, text mining | PubMed |
| Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy? | Biomolecules | 2024 | 39766344 | PubTator, text mining | PubMed |
| Identification and Evaluation of Angiogenesis-Related Proteins That Predict Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease. | J Cardiovasc Dev Dis | 2024 | 39728292 | PubTator, text mining | PubMed |
| Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study. | Medicine (Baltimore) | 2024 | 39705479 | PubTator, text mining | PubMed |
| DeepDoublet identifies neighboring cell-dependent gene expression. | Genomics Inform | 2024 | 39695909 | PubTator, text mining | PubMed |
| Familial chylomicronemia: New perspectives. | Clin Investig Arterioscler | 2024 | 39672668 | PubTator, text mining | PubMed |
| Adipocyte Angptl8 deletion improves glucose and energy metabolism and obesity associated inflammation in mice. | iScience | 2024 | 39640567 | PubTator, text mining | PubMed |
| Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S). | Lancet | 2024 | 39577453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=14